drugset / Trial / NCT02929056

Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations

NCT02929056 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate and compare healing characteristics, reduction in the size of the wound and to measure complete healing of the wound following the application of a biologic product dressing instead of the alginate dressing along with standard debridement and compression therapy versus the standard of care treatment for VLUs. The biologic product that will be used in this study is called AmnioExCel™.

Timeline

Start
2017-02-15
Primary completion
2018-09-06
Completion
2019-10-29

Outcome

Outcome not reported

Stopped (Business): “grant funding ended”

Drugs

EvaluationDrugModalityDoseRoute
Subject AmnioExCel Other / unclassified — —